Interleukin-17 antagonism inhibits acute but not chronic vascular rejection Article (Faculty180)

cited authors

  • Tang, J L; Subbotin, V M; Antonysamy, M A; Troutt, A B; Rao, A S; Thomson, A W

description

  • Blocking the action of interleukin (IL) 17 with an IL-17 receptor (R):Fc fusion protein inhibits T-cell proliferative responses to alloantigens and prolongs vascularized heart graft survival. In this study, we examined whether IL-17 antagonism could suppress the development of chronic rejection.

authors

publication date

  • 2001

published in

start page

  • 348

end page

  • 50

volume

  • 72